Basit öğe kaydını göster

dc.contributor.authorAkgul, Sinem
dc.contributor.authorBalci, Yasemin Isil
dc.contributor.authorUnal, Sule
dc.contributor.authorAlikasifoglu, Ayfer
dc.contributor.authorGurgey, Aytemiz
dc.date.accessioned2019-12-10T10:38:46Z
dc.date.available2019-12-10T10:38:46Z
dc.date.issued2009
dc.identifier.issn1300-7777
dc.identifier.urihttps://doi.org/
dc.identifier.urihttp://hdl.handle.net/11655/14078
dc.description.abstractHemophagocytic lymphohistiocytosis is a life-threatening condition of severe hyperinflammation that results from an uncontrolled proliferation of activated lymphocytes and histiocytes secreting high amounts of inflammatory cytokines. The immediate treatment strategies include immune suppressive therapy such as corticosteroid, etoposide and cyclosporin A. Herein, we present a 13-month-old infant who developed severe hypertrichosis after the administration of HLH-2004 treatment protocol. We discuss the various hypotheses regarding the causal relationship between cyclosporin A and hypertrichosis, emphasizing the importance of patient follow up. (Turk J Hematol 2009; 26: 154-6)
dc.language.isoen
dc.publisherAves Yayincilik
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHematology
dc.titleHypertrichosis: The Possible Side Effect Of Cyclosporin In An Infant With Hemophagocytic Lymphohistiocytosis Receiving Hlh-2004 Chemotherapy Protocol
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalTurkish Journal Of Hematology
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume26
dc.identifier.issue3
dc.identifier.startpage154
dc.identifier.endpage156
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster